Teva Pharmaceutical Industries Ltd. started production at its Ft 7 billion ($33 million) factory in Hungary, daily Napi Gazdaság reported. Teva, which is building another plant in Hungary for 2 billion Ft, will produce ingredients for cholesterol reduction drugs, the newspaper said. Hungary's government gave the company a 50% tax break for next year, according to Napi Gazdaság. Petah Tikva, Israel-based Teva, is seeking to cement its position as the world's biggest maker of low-cost copycat pharmaceuticals. The company employs 2,000 people at four Hungarian units aside from its new plant, having bought local drugmakers such as Biogal Rt. and Human Rt.
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.